Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The drug is currently in phase 3 trials for obesity and Type 2 diabetes
Researchers truncated the molecule to that bioactive fragment and called it Sermorelin (or GRF 1-29)
Lambrix, V., Reichelt, M., Mitchell-Olds, T., Kliebenstein, D
Impact of Selected Glucagon-like Peptide-1 Receptor Agonists on Serum Lipids, Adipose Tissue, and Muscle Metabolism-A Narrative Review
Discard immediately
Research Evidence The body of BPC-157 research consists primarily of preclinical animal studies, with very limited human clinical data
US$ 21.61
US$ 26.04
US$ 27.24
US$ 27.12
US$ 25.80
US$ 24.22
US$ 21.56
US$ 20.07
